Business Standard

Integrated Core Strategies (Asia) buys Biocon shares worth Rs 185 crore

Integrated Core Strategies (Asia) Pte on Tuesday bought shares of biopharmaceutical company Biocon for Rs 185 crore through an open market transaction

SAT stays Biocon insider trading order

Press Trust of India New Delhi
Integrated Core Strategies (Asia) Pte on Tuesday bought shares of biopharmaceutical company Biocon for Rs 185 crore through an open market transaction.
According to the bulk deal data available with the National Stock Exchange (NSE), Integrated Core Strategies (Asia) Pte purchased 80,61,599 shares at an average price of Rs 229.26 each share. The aggregate deal value is Rs 184.82 crore.
Details about the sellers could not be immediately ascertained.
On Tuesday, shares of Biocon closed marginally lower at Rs 229.50 apiece on NSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 28 2023 | 10:06 PM IST

Explore News